Transgenic plants for the production of veterinary vaccines

Immunology and Cell Biology

Volumn 83, Issue 3, 2005, Pages 229-238

  Dus Santos, María José ^a,b   Wigdorovitz, Andrés ^a,b  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Antigen expression; Bovine rotavirus (BRV); Bovine viral diarrhoea virus (BVDV); Foot and mouth disease virus (FMDV); Recombinant plant

Indexed keywords

PLANT BASED VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARGENTINA; BOVINE ROTAVIRUS; BOVINE VIRAL DIARRHEA VIRUS; CATTLE DISEASE; CONTROLLED STUDY; ECONOMIC ASPECT; FOOT AND MOUTH DISEASE VIRUS; IMMUNOGENICITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; TECHNOLOGY; TRANSGENIC PLANT; VACCINE PRODUCTION; VETERINARY MEDICINE; VIRUS;

ANIMALS; ANTIGENS, VIRAL; ARABIDOPSIS; CATTLE; CATTLE DISEASES; DIARRHEA VIRUSES, BOVINE VIRAL; FOOT-AND-MOUTH DISEASE VIRUS; MEDICAGO SATIVA; PLANTS, GENETICALLY MODIFIED; ROTAVIRUS; SOLANUM TUBEROSUM; VACCINES, EDIBLE; VACCINES, SYNTHETIC; VETERINARY MEDICINE; VIRAL PROTEINS; VIRAL VACCINES;

BOS TAURUS; BOVINAE; BOVINE ROTAVIRUS; FOOT-AND-MOUTH DISEASE VIRUS; MEDICAGO SATIVA;

EID: 20444388268     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01338.x     Document Type: Review

References (49)

1. Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK, Arntzen CJ. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl Acad. Sci. USA 1996; 93: 5335-40.
2. Haq TA, Mason HS, Clements JD, Arntzen CJ. Oral immunization with recombinant bacterial antigen produced in transgenic plants. Science 1995; 268: 714-16.
3. Arakawa T, Chong DKX, Langridge WHR. Efficacy of a food plant based oral cholera toxin B subunit vaccine. Nat. Biotechnol. 1998; 16: 292-7.
4. Gómez N, Wigdorovitz A, Castañón A et al. Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus. Arch. Virol. 2000; 145: 1725-32.
5. Wigdorovitz A, Carrillo C, Dus Santos MJ et al. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 1999; 255: 347-53.
6. Yu J, Langridge WH. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. Biotechnol. 2001; 19: 548-52.
7. Wigdorovitz A, Mozgovoj M, Dus Santos MJ et al. Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants. J. Gen. Virol. 2004; 85: 1825-32.
8. Brown F. Vaccination against foot and mouth disease virus. Vaccine 1992; 10: 1022-6.
9. Carrillo C, Wigdorovitz A, Oliveros JC et al. Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. J. Virol. 1998; 72: 1688-90.
10. Wigdorovitz A, Carrillo C, Trono K et al. Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants. Virol. Immunol. 2001; 14: 49-57.
11. Dus Santos MJ, Wigdorovitz A, Trono K et al. A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine 2002; 20: 1141-7.
12. Gil F, Brun A, Wigdorovitz A et al. High-yield expression of a viral peptide vaccine in transgenic plants. FEBS Lett. 2001; 488: 13-17.
13. Sojikul P, Buehner N, Mason HS. A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells. Proc. Natl Acad. Sci. USA 2003; 100: 2209-14.
14. Walmsley AM, Alvarez ML, Jin Y et al. Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato. Plant Cell Rep. 2003; 21: 1020-26.
15. Saiz JC, Cairó J, Medina M et al. Unprocessed Foot and Mouth Disease Virus capsid precursor displays discontinuous epitopes involved in viral neutralization. J. Virol. 1994; 68: 4557-64.
16. Mayr GA, Chisangram J, Grubman MJ. Development of replication - defective adenovirus serotipe 5 containing the capsid and 3C protease coding regions of Foot and Mouth Disease Virus as a vaccine candidate. Virology 1999; 263: 496-506.
17. Kapikian A, Chanock R. Rotaviruses. In: Fields BN, Knipe DM, Howley PM et al. (eds) Virology. Philadelphia: Lippincott-Raven Publishers, 1996; 1657-708.
18. Offit PA, Clark HF. Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody. J. Infect. Dis. 1985; 6: 1152-8.
19. Fernandez FM, Conner ME, Parwani AV et al. Isotype-specific antibody responses to rotavirus and virus proteins in cows inoculated with subunit vaccines composed of recombinant SAH rotavirus core-like particles (CLP) or virus-like particles (VLP). Vaccine 1996; 14: 1303-312.
20. Kim Y, Nielsen PR, Hodgings D, Chang KO, Saif LJ. Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines. Vaccine 2002; 20: 1248-58.
21. Saif LJ, Redman DR, Smith KL, Theil KW. Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from immunized or nonimmunized cows. Infect. Immun. 1983; 3: 1118-31.
22. Bolin SR. Control of bovine viral diarrhea virus. Sci. Technol. 1990; 9: 163-71.
23. Corapi WV, Donis RO, Dubovi EJ. Characterization of a panel of monoclonal antibodies and their use in the study of the antigenic diversity of bovine viral diarrhea virus. Am. J. Vet. Res. 1990; 51: 1388-94.
24. Kelling CL. Planning Bovine Viral Diarrhea Virus vaccination programs. Vet. Med. 1991; 91: 873-7.
25. Van Oirschot JT, Bruschke CJ, van Rijn P. Vaccination of cattle against bovine viral diarrhea. Vet. Microbiol. 1999; 64: 169-83.
26. Deregt D, Bolin SR, van den Hurk J, Ridpath JF, Gilbert SA. Mapping of a type 1-specific and a type-common epitope on the E2 (gp53) protein of bovine viral diarrhea virus with neutralization escape mutants. Virus Res. 1998; 53: 81-90.
27. Fulton RW, Saliki JT, Burge LJ et al. Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay. Clin. Diagn. Lab. Immunol. 1997; 4: 380-83.
28. Paton DJ, Lowings JP, Barrett AD. Epitope mapping of the gp53 envelope protein of bovine viral diarrhea virus. Virology 1992; 190: 763-72.
29. Erratum in: Virology 1992; 191: 1013.
30. Bruschke CJ, Moormann RJ, van Oirschot JT, van Rijn PA. A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge. Vaccine 1997; 15: 1940-45.
31. Kweon CH, Yoon SH, Lee YS. Expression of envelope protein (E2) of bovine viral diarrhea virus in insect cells. J. Vet. Med. Sci. 1997; 59: 415-19.
32. Carrington J, Freed D. Cap-independent enhancement of translation by a plant potyvirus 5′ nontranslated region. J. Virol. 1990; 64: 1590-97.
33. Carrington J, Freed D, Leinicke A. Bipartite signal sequence mediates nuclear translocation of the plant potyviral NIa protein. Plant Cell 1991; 3: 953-62.
34. Tariq A, Haq S, Masson H, Clements JD, Artzen CJ. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 1995; 268: 714-19.
35. DiMarchi R, Brooke G, Gale C, Cracknell V, Doel T, Mowat N. Protection in cattle against foot and mouth disease by a synthetic peptide. Science 1986; 232: 639-47.
36. Kleid DG, Yansura D, Small B et al. Cloned viral protein vaccine for foot and mouth disease: responses in cattle and swine. Science 1981; 214: 1125-9.
37. Morgan DO, Moore DM. Protection in cattle and swine against foot and mouth disease (FMD) with biosynthetic peptide vaccine. Am. J. Vet. Res. 1989; 15: 473-97.
38. Zamorano P, Wigdorovitz A, Perez-Filgueira M et al. A 10 amino-acid linear sequence of VP1 of foot and mouth disease virus (FMDV) containing B and T-cell epitopes induces protection in mice. Virology 1995; 212: 614-21.
39. Chiapello H, Lisacek F, Caboche M, Henaut A. Codon usage and gene function are related in sequences of Arabidopsis thaliana. Gene 1998; 16: 209 (1-2): GC1-GC38.
40. Abrams CC, King AMQ, Belshman GJ. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. J. Gen. Virol. 1995; 76: 3089-98.
41. Grubman MJ, Lewis SA, Morgan DO. Protection of swine against foot-and-mouth disease with viral capsid proteins expressed in heterologous systems. Vaccine 1993; 11: 825-9.
42. Ijaz MK, Attah-Poku SK, Redmond MJ et al. Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus. J. Virol. 1991; 65: 3106-113.
43. Mason HS, Lam DM-K, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl Acad. Sci. USA 1992; 89: 11 745-9.
44. Castañón S, Marín MS, Martín Alonso JM et al. Immunization with potato plants expressing VP60 proteins protects against rabbit hemorrhagic disease virus. J. Virol. 1999; 73: 4452-5.
45. Mason HS, Haq TA, Clements JD, Arntzen CJ. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 1998; 16: 1335-42.
46. Richter LJ, Thanavala Y, Arntzen CJ, Mason HS. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 2000; 18: 1167-71.
47. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 2000; 182: 302-305.
48. Varsani A, Williamson AL, Rose RC, Jaffer M, Rybicki EP. Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi. Arch. Virol. 2003; 148: 1771-86.
49. Chinsangaram J, Beard C, Mason PW, Zellner MK, Ward G, Grubman MJ. Antibody response in mice inoculated with DNA expressing foot and mouth disease virus capsid proteins. J. Virol. 1998; 72: 4454-7.